$5.04
Sana Biotechnology, a company that develops platforms to replace or repair cells in our bodies, wrapped an upsized IPO at $588 million.
Morgan Stanley, Goldman Sachs Group, JPMorgan and BofA Securities were the bookrunners for the deal.Our top picks for where to buy Sana Biotechnology stock
How to buy Sana Biotechnology Inc stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – SANA. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Sana Biotechnology Inc stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Sana Biotechnology Inc stock price (NASDAQ: SANA)
Use our graph to track the performance of SANA stocks over time.Sana Biotechnology Inc shares at a glance
Latest market close | $5.04 |
---|---|
52-week range | $2.75 - $12.00 |
50-day moving average | $5.54 |
200-day moving average | $6.67 |
Wall St. target price | $13.60 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-1.14 |
Is it a good time to buy Sana Biotechnology Inc stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Sana Biotechnology Inc price performance over time
Historical closes compared with the close of $5.04 from 2024-09-06
1 week (2024-08-30) | -16.69% |
---|---|
1 month (2024-08-07) | 6.78% |
3 months (2024-06-07) | -27.79% |
6 months (2024-03-07) | -47.39% |
1 year (2023-09-07) | -9.03% |
---|---|
2 years (2022-09-07) | -26.53% |
3 years (2021-09-07) | 23.69 |
5 years (2019-09-03) | N/A |
Sana Biotechnology Inc financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -27.91% |
Return on equity TTM | -70.51% |
Profit margin | 0% |
Book value | $1.53 |
Market Capitalization | $1.3 billion |
TTM: trailing 12 months
Sana Biotechnology Inc share dividends
We're not expecting Sana Biotechnology Inc to pay a dividend over the next 12 months.
Sana Biotechnology Inc share price volatility
Over the last 12 months, Sana Biotechnology Inc's shares have ranged in value from as little as $2.745 up to $12. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sana Biotechnology Inc's is 1.451. This would suggest that Sana Biotechnology Inc's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
To put Sana Biotechnology Inc's beta into context you can compare it against those of similar companies.
- Editas Medicine (EDIT.US): 2.002
- Intellia Therapeutics (NTLA.US): 1.811
- Pacific Biosciences of California (PACB.US): 2.034
Sana Biotechnology Inc overview
Sana Biotechnology, Inc. , a biotechnology company, focuses on utilizing engineered cells as medicines. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, B-cell-mediated autoimmune, and others. The company's product candidates include SC291 that is used as allogeneic cell therapies for hematologic malignancies; ARDENT for a potential treatment for non-Hodgkin's lymphoma, and chronic lymphoblastic leukemia; GLEAM, to treat multiple autoimmune disorders that involve production of autoimmune antibodies, including lupus nephritis, extrarenal lupus, antineutrophil cytoplasmic antibody -associated vasculitis, and others. It is developing SC262 to treat patients with relapsed and/or refractory B-cell malignancies; SC255 for multiple myeloma treatment; SC379, a therapy for patients with certain central nervous system disorders healthy allogeneic glial progenitor cells; SC451, a product candidate to treat diabetes, with an initial focus on type 1 diabetes mellitus; and UP421 that reduces long-term exogenous insulin dependence. The company has an option and license agreement with Beam Therapeutics Inc. for use of Beam's proprietary CRISPR Cas12b nuclease editing technology to research, develop, and commercialize engineered cell therapy products; and a license agreement with Harvard College to access certain intellectual property for the development of hypoimmune-modified cells.
Frequently asked questions
What percentage of Sana Biotechnology Inc is owned by insiders or institutions?Currently 8.598% of Sana Biotechnology Inc shares are held by insiders and 90.429% by institutions. How many people work for Sana Biotechnology Inc?
Latest data suggests 328 work at Sana Biotechnology Inc. When does the fiscal year end for Sana Biotechnology Inc?
Sana Biotechnology Inc's fiscal year ends in December. Where is Sana Biotechnology Inc based?
Sana Biotechnology Inc's address is: 188 East Blaine Street, Seattle, WA, United States, 98102 What is Sana Biotechnology Inc's ISIN number?
Sana Biotechnology Inc's international securities identification number is: US7995661045
More guides on Finder
-
Options profit calculator
Use this calculator to quickly see potential outcomes of your options trades.
-
Best options trading platforms of 2024
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
-
What is a covered call?
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
-
GSD Capital review 2024
A look at GSD Capital’s highlights, limitations, fees and investment strategies.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 E*TRADE competitors worth your time
Looking for a discount broker like E*TRADE that offers something different? Here are some of the top alternatives to consider.
-
Charles Schwab vs. Fidelity
Charles Schwab and Fidelity are two powerhouse trading platforms for beginner and advanced investors.
-
Interactive Brokers review 2024: Tailored trading and investing
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
-
Top 15 tech stocks to invest in for 2024
Discover the top tech stocks poised to lead innovation and offer substantial growth opportunities.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Ask a question